Gilead's remdesivir shaved 5 days off COVID-19 recovery time, reduced risk of death in some

Julie Steenhuysen, Reuters Posted at Oct 09 2020 06:19 AM Gilead Sciences Inc pharmaceutical company is seen after they announced a Phase 3 Trial of the investigational antiviral drug Remdesivir in patients with severe coronavirus disease (COVID-19), during the outbreak of the coronavirus disease (COVID-19), in Oceanside, California, US, April 29, 2020. Mike Blake, Reuters/File CHICAGO - Final data from Gilead Sciences Inc's antiviral drug remdesivir showed the treatment cut COVID-19 recovery time by five days compared with patients who got a placebo, one day faster than indicated in preliminary data, the company and researchers said on Thursday. In patients who were on oxygen when they first got the drug, remdesivir - sold under the brand Veklury - reduced recovery time by seven days compared with placebo after 29 days, according to the 1,062-patient study, published in the New England Journal of Medicine. The final study looked at data at 29 days of treatment, versus a preliminary study released in May that reported results after 15 days. Gilead's drug was among the first to be used as a treatment for the novel coronavirus, and was one of the drugs recently used to treat US President Donald Trump. Remdesivir received emergency use authorization from the U.S. Food and Drug Administration on May 1, and has since been authorized for use in several other countries. Results of the overall study suggested the drug may reduce mortality, but the benefit was not statistically significant. In a separate analysis looking just at patients who received oxygen, however, the drug appeared to reduce the risk of death by 72 percent at day 15, and 70 percent by day 29. With this analysis, "we now have data suggesting that giving remdesivir to patients on oxygen may significantly reduce their chances of death compared to other subgroups," Dr. Andre Kalil, an infectious disease expert at the University of Nebraska Medical Center and the study's principal investigator, said in a press release. Read More: remdesivir Gilead Gilead Sciences Inc COVID-19 coronavirus COVID-19 treatment coronavirus treatment Trump Donald Trump Veklury ANC

Comments

Post a Comment

Popular posts from this blog

POPCOM, gagamit ng ‘digital platforms’ para pagtibayin ang mga ugnayang pampamilya

Mas pinalalawig ng Komisyon sa Populasyon at Pagpapaunlad (POPCOM) ang adhikain nitong pagpapalaganap at pagpapabuti ng pakikipag-ugnayan ng mga nakakatandang Pilipino sa kanilang mga anak na nagdadalaga at nagbibinata. Nitong Setyembre 21, ang POPCOM ay nagsagawa ng isang “parent-teen talk webinar” gamit ang Zoom, kung saan ang isang “interactive program” ang nagbigay ng naaayon na kaalaman at kasanayan sa mga magulang, habang tumulong ito sa mga anak na teenager na maabot ang kanilang buong potensyal. Hinikayat din nito ang mga nanay at tatay na sumali sa malayang usapan, lalo na sa mga usapin ukol sa sex at sekswalidad, na nakikitang makakatulong upang bumaba ang mga bilang ng mga pagbubuntis sa hanay ng mga kabataan. Maaaring mapanood ang webinar sa https://youtu.be/lZ9jrJCjYas. Ayon kay Ikalawang Kalihim (Undersecretary) Juan Antonio A. Perez III, MD, MPH, “ang webinar ay naging isang tagapag-simula at ‘padaluyan’ ng pag-uu
Read more

UP Diliman Professors Share Scientists’ Procurement Struggles at Senate Hearing

By Harvey Sapigao Senate hearing of the revised procurement law (Photo credit: Senate of the Philippines) College of Science (CS) Dean Giovanni Tapang held up a little white device as he finished his presentation. “This is a ₱150,000 component,” he described. “Isa lang gumagawa nito sa buong mundo, pero ang hirap pilitin sila na magregister sa PhilGEPS,” he continued, referring to the requirement that foreign companies must first register to the Philippine Government Electronic Procurement System (PhilGEPS) before they can sell products to local scientists. Marine Science Institute (MSI) Deputy Director Dr. Irene Rodriguez explained that the small device is a resin that filters metals in water. “May budget tayo,” she said, “pero ang problema ko ay ‘yung resin na ito.” This and other bottlenecks brought about by the procurement law, or the Government Procurement Reform Act (RA 9184), slow down research and development in the country. UPD leaders were invited to the Senate he
Read more

Gaza war rages into fourth month as Blinken tours Middle East Adel Zaanoun with Ilan Ben Zion in Jerusalem, --- Agence France-Presse

The Israel-Hamas war raging in Gaza entered its fourth month on Sunday as the army again pounded the besieged Palestinian territory and US top diplomat Antony Blinken was back in the region seeking to avoid a wider escalation. Israeli airstrikes overnight and early Sunday killed at least 64 people in the Hamas-run Palestinian territory, said its health ministry. It said two journalists were killed when their car was struck. The ministry, medics, and witnesses identified them as Mustafa Thuria, a video stringer for Agence France-Presse, and Hamza Wael Dahdouh, the son of Al Jazeera's bureau chief in Gaza who earlier lost his wife and two other children in an Israeli strike. Israeli bombardment also claimed other civilian lives in the southern city of Khan Yunis and in the Rafah area near the Egyptian border, where many of the territory's displaced people have sought refuge, AFP correspondents reported. Relatives were mourning the dead at Khan Yunis' European Hospital, am
Read more